Royalty Pharma (RPRX) — Upcoming Catalysts
FDA PDUFA dates, advisory-committee meetings, and Phase 2/3 readout windows for Royalty Pharma, built from public data lanes (ClinicalTrials.gov and official sources). Each row links to its source.
For informational purposes only — not investment advice. Track RPRX live on Mooboard →
No upcoming catalysts in the public data lanes right now.
How Royalty Pharma has moved — past-year price reactions
How binary is RPRX? Its typical daily move, how often it swings ±10%, and its biggest single-day moves over the last year — useful context for sizing around a catalyst.
0.9%
typical day (1Y)
0
±10% days
22.9%
annualized vol
250
trading days
Largest single-day moves
- +6.8%2025-11-05no matched headline
- -5.4%2025-11-07no matched headline
- +3.9%2026-07-16no matched headline
- -3.7%2025-08-11no matched headline
- -3.7%2026-03-05no matched headline
- +3.6%2026-07-02no matched headline
Real daily price moves over the past year — not every move is a catalyst, and headlines (where shown) are a possible same-day driver, not confirmed causation.
See the full biopharma catalyst calendar across all covered companies.